Friess, H., Langrehr, J. M., Oettle, H., Raedle, J., Niedergethmann, M., Dittrich, C., . . . Nippgen, J. (2006). A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer. BioMed Central.
Chicago Style CitationFriess, Helmut, et al. A Randomized Multi-center Phase II Trial of the Angiogenesis Inhibitor Cilengitide (EMD 121974) and Gemcitabine Compared With Gemcitabine Alone in Advanced Unresectable Pancreatic Cancer. BioMed Central, 2006.
Cita MLAFriess, Helmut, et al. A Randomized Multi-center Phase II Trial of the Angiogenesis Inhibitor Cilengitide (EMD 121974) and Gemcitabine Compared With Gemcitabine Alone in Advanced Unresectable Pancreatic Cancer. BioMed Central, 2006.